Zelira Therapeutics Limited (ASX:ZLD)
0.3500
0.00 (0.00%)
Apr 24, 2025, 3:24 PM AEST
Zelira Therapeutics Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2016 - 2019 |
Net Income | -4.84 | -36.57 | -5.57 | -11.95 | -8.55 | -7.02 | Upgrade
|
Depreciation & Amortization | 0.35 | 0.48 | 0.55 | 0.59 | 0.47 | 0.28 | Upgrade
|
Asset Writedown & Restructuring Costs | 29.83 | 29.83 | -1.14 | -1.29 | -1.38 | -1.03 | Upgrade
|
Loss (Gain) From Sale of Investments | - | - | - | 0.07 | 0.18 | 0.11 | Upgrade
|
Stock-Based Compensation | 0.04 | 0.04 | 0.4 | 2.69 | 1.3 | 0.54 | Upgrade
|
Provision & Write-off of Bad Debts | - | - | -1.46 | 1.51 | - | - | Upgrade
|
Other Operating Activities | -32.39 | 0.11 | -0.89 | -0.36 | -0.08 | 0.32 | Upgrade
|
Change in Accounts Receivable | -0.21 | -0.21 | 0.28 | -0.12 | -0.12 | -0.08 | Upgrade
|
Change in Inventory | 0.28 | 0.28 | 0.36 | -1.09 | -0.87 | - | Upgrade
|
Change in Accounts Payable | 1.67 | 1.67 | 0.23 | 0.53 | 0.43 | -0.05 | Upgrade
|
Operating Cash Flow | -5.29 | -4.39 | -7.25 | -9.43 | -8.62 | -6.94 | Upgrade
|
Capital Expenditures | - | - | - | - | - | -0.02 | Upgrade
|
Cash Acquisitions | - | - | - | - | - | 0.19 | Upgrade
|
Investment in Securities | - | - | 0.74 | - | - | - | Upgrade
|
Other Investing Activities | 0.92 | 0.92 | 2.09 | -0.21 | 1.38 | 0.93 | Upgrade
|
Investing Cash Flow | 0.92 | 0.92 | 2.83 | -0.21 | 1.38 | 1.11 | Upgrade
|
Short-Term Debt Issued | - | 3.92 | - | - | - | - | Upgrade
|
Total Debt Issued | 4.36 | 3.92 | - | - | - | - | Upgrade
|
Net Debt Issued (Repaid) | 4.36 | 3.92 | - | - | - | - | Upgrade
|
Issuance of Common Stock | - | - | 1.77 | 7.1 | 10.62 | 4.79 | Upgrade
|
Other Financing Activities | - | - | - | - | -0.09 | -0.29 | Upgrade
|
Financing Cash Flow | 4.36 | 3.92 | 1.77 | 7.1 | 10.53 | 4.5 | Upgrade
|
Foreign Exchange Rate Adjustments | -0.02 | -0.02 | 0.05 | 0.31 | -0.02 | -0.05 | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | - | - | - | -0 | - | Upgrade
|
Net Cash Flow | -0.03 | 0.44 | -2.6 | -2.22 | 3.27 | -1.38 | Upgrade
|
Free Cash Flow | -5.29 | -4.39 | -7.25 | -9.43 | -8.62 | -6.95 | Upgrade
|
Free Cash Flow Margin | -12934.93% | -4621.90% | -2407.36% | -611.91% | -1299.02% | - | Upgrade
|
Free Cash Flow Per Share | -0.47 | -0.39 | -0.72 | -1.17 | -1.30 | -1.43 | Upgrade
|
Cash Interest Paid | 0.19 | 0.04 | 0.03 | - | - | - | Upgrade
|
Levered Free Cash Flow | -3.41 | -4.02 | -2.64 | -5.69 | -4.72 | -3.93 | Upgrade
|
Unlevered Free Cash Flow | -2.55 | -3.55 | -2.59 | -5.66 | -4.69 | -3.92 | Upgrade
|
Change in Net Working Capital | -1.12 | 0.38 | -0.94 | 0.69 | 0.61 | -0.12 | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.